Balance Sheet Data

Edesa Biotech, Inc. (EDSA)

$0.96

-0.03 (-3.03%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 10.305.037.217.847.0918.8825.8735.4448.5466.50
Total Cash (%)
Account Receivables 0.040.220.093.301.261.752.403.294.506.16
Account Receivables (%)
Inventories 0.220.430.350.480.650.891.231.682.303.15
Inventories (%)
Accounts Payable ----------
Accounts Payable (%)
Capital Expenditure -0.38-0.01-0.03-0.01-5.66-1.88-2.57-3.52-4.83-6.61
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.